期刊文献+

CDl3/APN与宫颈癌的关系

下载PDF
导出
摘要 CDl3/APNfamino—peptidase N APN)是一种将氨基酸从寡肽N末端切除的膜结合糖蛋白(氨基肽酶N),属于结合锌的金属蛋白酶超家族,其正常功能是在体内通过单一机制或多个机制协同作用参与病理生理过程,主要包括蛋白水解酶酶切作用,作为信号分子参与信号转导,作为细胞表面受体等机制发挥作用。
出处 《中国急救复苏与灾害医学杂志》 2011年第7期654-655,共2页 China Journal of Emergency Resuscitation and Disaster Medicine
  • 相关文献

参考文献19

  • 1Riemann D, Kehlen A, Langner J. CD13-not just a marker in leukemia typing. Immunol Today, 1999,20(2):83-88.
  • 2Bordessoule D, Jones M, Gatter KC, et al. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br J Haematol, 1993,83(3):370-383.
  • 3Alliot F, Rutin J, Leenen PJ, et al. Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J Neuros/:i Res,1999,58(3):367-378.
  • 4Ashmun RA, Look AT. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood, 1990,75(2):462-469.
  • 5Riemann D, Kehlen A, Langner J. CD13-not just a marker in leukemia typing. Immuanl Today, 1999,20(2): 83-88.
  • 6Shimizu T, Tan i K, Hase K, et al. CD13 / aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum,2002,46(9): 2330-2338.
  • 7Bonewia A, Zelus BD, Wentworth DE, et al. Identification of areceptor-binding domain of the spike glycoprotein of Human coronavirus HCoV-229. J Virel, 2003,77(4): 2530-2538.
  • 8Breslin JJ, Mork I, Smith MK, et al. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C. J Virel, 2003,77(7) :4435-4438.
  • 9Kramer W, Girbig F, Corsiere D, et ai. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J Bid Chem, 2005,280(2):1306-1320.
  • 10Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer, 1993,54(1):137-143.

二级参考文献26

  • 1[1]Folkman J.Tumor angiogenesis:therapeutic implications[J].N Engl J Med,1971,285:1182-1186.
  • 2[2]Collins I,Workman P.New appmachm to molecular cancer therapeutics[J].Nat Chem Biol,2006,2:689-700.
  • 3[3]Ferrara N,Hillan KJ,Gerber HP,et al.Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer[J].Nat Rev Drug Discov,2004,3:391-400.
  • 4[4]Wang Y,Fei D,Vandedaan M,et al.Biological activity of bevacizumab,a humanized anti-VEGF antibody in vitro[J].Angiogenesis,2004,7:335-345.
  • 5[5]Keiko Shibuya,Ritsuko Komaki,Tomoaki Shintani,et al.Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non -small-cell lung cancer[J].Int J f Radia Oncol Biol Phys,69:1534-1543.
  • 6[6]Dings RP,Chen X,Hellebrekers DM,et al.Design of nonpeptidic topomimeties of antiangiogenlc proteins with antitumor activities[J].J Natl Cancer Inst,2006,98:932-936.
  • 7[7]Nakamura K,Taguchi E,Miura T,et al.KRN951,a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine,has antitumor activities and affects functional vascular properties[J].Urol Oncol,2007,25:359-360.
  • 8[8]Feng-Yao Tang,En-Pei Isabel Chiang,Chung-Jin Shih.Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells[J].J Nutr,2007,6:391-399.
  • 9[9]Yu Y,Moulton KS,Khan MK,et al.Eselectin is required for the antiangiogenic activity of endostatm[J].Proe Nail Acad Sei USA,2004,101:8005-8010.
  • 10[10]Van Beijnum JR,Griffioen AW.In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles[J].Biochim Biophys Acta,2005,1755:121-134.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部